APA (7th ed.) Citation

Pietrantonio, F., Maggi, C., Bartolomeo, M. D., Facciorusso, M. G., Perrone, F., Testi, A., . . . Braud, F. d. (2014). Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type status. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Pietrantonio, Filippo, et al. Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-type Status. Public Library of Science (PLoS), 2014.

MLA (9th ed.) Citation

Pietrantonio, Filippo, et al. Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-type Status. Public Library of Science (PLoS), 2014.